These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 19997577)

  • 1. Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting.
    Sharma RK; Reddy HK; Singh VN; Sharma R; Voelker DJ; Bhatt G
    Vasc Health Risk Manag; 2009; 5():965-72. PubMed ID: 19997577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary artery disease: Platelet activity: an obstacle for successful PCI.
    Gawaz M; Geisler T
    Nat Rev Cardiol; 2009 Jun; 6(6):391-2. PubMed ID: 19471282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.
    Stuckey TD; Kirtane AJ; Brodie BR; Witzenbichler B; Litherland C; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Gurbel PA; Mehran R; Généreux P; Ben-Yehuda O; Simonton CA; Stone GW;
    JACC Cardiovasc Interv; 2017 Aug; 10(16):1607-1617. PubMed ID: 28780034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.
    Tentzeris I; Jarai R; Farhan S; Brozovic I; Smetana P; Geppert A; Wojta J; Siller-Matula J; Huber K
    Thromb Haemost; 2010 Dec; 104(6):1211-8. PubMed ID: 20941464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial.
    Wiviott SD; Braunwald E; McCabe CH; Horvath I; Keltai M; Herrman JP; Van de Werf F; Downey WE; Scirica BM; Murphy SA; Antman EM;
    Lancet; 2008 Apr; 371(9621):1353-63. PubMed ID: 18377975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post percutaneous coronary intervention antiplatelet therapy: current perceptions, prospects and perplexity.
    Pant S; Neupane P; Ramesh KC; Barakoti M
    Cardiol J; 2011; 18(6):712-7. PubMed ID: 22113766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary artery stenting in patients treated by clopidogrel without aspirin.
    Rott D; Leibowitz D; Amit G; Zahger D; Weiss AT
    Int J Cardiol; 2009 Apr; 133(2):279-81. PubMed ID: 18178268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel resistance: myth or reality?
    Barsky AA; Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):47-53. PubMed ID: 16703219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.
    Mishkel GJ; Aguirre FV; Ligon RW; Rocha-Singh KJ; Lucore CL
    J Am Coll Cardiol; 1999 Dec; 34(7):1884-90. PubMed ID: 10588198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of subacute thrombosis associated with clopidogrel resistance after implantation of a zotarolimus-eluting stent.
    Arima M; Matsuda A; Nitta M; Yoshida K; Shimizu M
    Heart Vessels; 2012 Jan; 27(1):106-9. PubMed ID: 21445598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stents.
    Zimarino M; Renda G; De Caterina R
    Drugs; 2005; 65(6):725-32. PubMed ID: 15819586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy with clopidogrel and aspirin after coronary stenting.
    Kolansky DM; Klugherz BD; Curran SC; Herrmann HC; Magness K; Wilensky RL; Hirshfeld JW
    Catheter Cardiovasc Interv; 2000 Jul; 50(3):276-9. PubMed ID: 10878621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin and platelet adenosine diphosphate receptor antagonists in acute coronary syndromes and percutaneous coronary intervention: role in therapy and strategies to overcome resistance.
    Depta JP; Bhatt DL
    Am J Cardiovasc Drugs; 2008; 8(2):91-112. PubMed ID: 18422393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic and bleeding events after coronary stenting according to clopidogrel and aspirin platelet reactivity: VerifyNow French Registry (VERIFRENCHY).
    Rangé G; Yayehd K; Belle L; Thuaire C; Richard P; Cazaux P; Barbou F; Köning R; Chassaing S; Teiger E; Berthier R; Decomis MP; Claudel JP; Delarche N; Brunel P; De Poli F; Dupouy P; Beygui F; Albert F; Collet JP; Montalescot G;
    Arch Cardiovasc Dis; 2014 Apr; 107(4):225-35. PubMed ID: 24794216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome.
    Cuisset T; Frere C; Quilici J; Barbou F; Morange PE; Hovasse T; Bonnet JL; Alessi MC
    J Thromb Haemost; 2006 Mar; 4(3):542-9. PubMed ID: 16371119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of two-year clopidogrel + aspirin in abolishing the risk of very late thrombosis after drug-eluting stent implantation (from the TYCOON [two-year ClOpidOgrel need] study).
    Tanzilli G; Greco C; Pelliccia F; Pasceri V; Barillà F; Paravati V; Pannitteri G; Gaudio C; Mangieri E
    Am J Cardiol; 2009 Nov; 104(10):1357-61. PubMed ID: 19892050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.